SCHEMBL26554452

SCHEMBL26554452

Pc1ccc(-c2ccc3ccc(-c4ccc(-c5cccc6ccccc56)nc4)cc3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.40
CYP11B1 P15538 4/20 0.39
CYP11B2 P19099 4/20 0.39
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
CA12 O43570 4/20 0.36
CA9 Q16790 4/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
ENPP3 O14638 1/20 0.35
ENPP1 P22413 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CCNT1 O60563 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CDK9 P50750 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26554461 0.87 PIM1 (0.40) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26567174 0.87 CYP11B1 (0.43) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26554492 0.87 BMX (0.42) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26548693 0.87 CASP3 (0.45) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26564770 0.86 CYP11B1 (0.44) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26548697 0.85 CYP11B1 (0.39) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26553044 0.83 CA12 (0.50) PIM1CA12CA9CA1CA2
SCHEMBL26548180 0.83 L3MBTL1 (0.46) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26551572 0.83 PIM1 (0.41) PIM1CYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26551585 0.83 BMX (0.43) PIM1CYP11B1CYP11B2CYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 PIM1 1158/4885CYP11B1 1676/4885CYP11B2 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.